🇺🇸 FDA
Patent

US 9533025

Method for treating chemotherapy-induced male infertility

granted A61KA61K31/255A61K38/09

Quick answer

US patent 9533025 (Method for treating chemotherapy-induced male infertility) held by The Board of Regents of the University of Texas System expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/255, A61K38/09, A61K38/1825, A61K38/185